A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
Category: Providers
The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...] …
Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...] …
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...] …
A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...] …
Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...] …
A late amendment to Indiana’s newly enacted budget law grants the state broad authority to restrict how 340B drugs are [...] …
The Oregon Legislature yesterday sent a 340B contract pharmacy access bill to the state’s governor, shortly after Illinois lawmakers failed [...] …
Pharmaceutical giant AbbVie has sued Hawaii over its 340B contract pharmacy access law just three days after the governor signed [...] …
The Department of Health and Human Services (HHS) has submitted proposed 340B rebate guidance for regulatory review—but it is unclear [...] …